Content area
Full Text
Headnote
Gov't requests improvements at Elyria facilities
ELYHIA, Ohio - The U.S. Food and Drug Administration (FDA) has turned up the heat on Invacare.
The FDA has proposed Invacare suspend certain operations at its corporate and wheelchair manufacturing facilities in Elyria until the manufacturer makes changes to its operations.
Invacare announced Dec. 8 that it will work with the FDA to negotiate an agreement, called a consent decree, to address its concerns.
"We're going to get this fixed," said Gerald Blouch, Invacare's president and CEO. "We're not victims here. We're taking this on and, at the end of the day, it will be a good thing."
Earlier this year, the FDA sent a warning letter to Invacare detailing concerns...